PT88556B
(pt)
*
|
1987-09-28 |
1992-11-30 |
Smithkline Biolog |
Processo de integracao genomica estavel e de expressao de uma sequencia de cadificacao estranha, em leveduras
|
KR0184860B1
(ko)
*
|
1988-11-11 |
1999-04-01 |
메디칼 리써어치 카운실 |
단일영역 리간드와 이를 포함하는 수용체 및 이들의 제조방법과 이용(법)
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
US6291159B1
(en)
*
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for producing polymers having a preselected activity
|
US6969586B1
(en)
*
|
1989-05-16 |
2005-11-29 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
US6680192B1
(en)
|
1989-05-16 |
2004-01-20 |
Scripps Research Institute |
Method for producing polymers having a preselected activity
|
US6291161B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertiore
|
GB8920211D0
(en)
*
|
1989-09-07 |
1989-10-18 |
Ici Plc |
Diagnostic method
|
US5658772A
(en)
*
|
1989-12-22 |
1997-08-19 |
E. I. Du Pont De Nemours And Company |
Site-specific recombination of DNA in plant cells
|
WO1991009957A1
(en)
*
|
1989-12-22 |
1991-07-11 |
E.I. Du Pont De Nemours And Company |
Site-specific recombination of dna in plant cells
|
US5580734A
(en)
*
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
DE69114500T2
(de)
*
|
1990-07-13 |
1996-06-13 |
Transkaryotic Therapies Inc |
Verfahren zum absuchen einer bibliothek.
|
WO1992015694A1
(en)
*
|
1991-03-08 |
1992-09-17 |
The Salk Institute For Biological Studies |
Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
|
WO1992022650A1
(en)
*
|
1991-06-17 |
1992-12-23 |
Life Technologies, Inc. |
Recombination-facilitated multiplex analysis of dna fragments
|
WO1993001283A1
(en)
*
|
1991-07-08 |
1993-01-21 |
The United States Of America As Represented By The Secretary Of Agriculture |
Selection-gene-free transgenic plants
|
EP0626999A4
(en)
*
|
1992-01-24 |
1997-04-09 |
Life Technologies Inc |
Modulation of enzyme activities in the -i(in vivo) cloning of dna.
|
WO1993024642A1
(en)
*
|
1992-06-04 |
1993-12-09 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6261808B1
(en)
|
1992-08-04 |
2001-07-17 |
Replicon, Inc. |
Amplification of nucleic acid molecules via circular replicons
|
US5834202A
(en)
*
|
1992-08-04 |
1998-11-10 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
US5614389A
(en)
*
|
1992-08-04 |
1997-03-25 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
WO1994003624A1
(en)
*
|
1992-08-04 |
1994-02-17 |
Auerbach Jeffrey I |
Methods for the isothermal amplification of nucleic acid molecules
|
US5733733A
(en)
*
|
1992-08-04 |
1998-03-31 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
GB9302798D0
(en)
*
|
1993-02-12 |
1993-03-31 |
Medical Res Council |
Improvements in or relating to cloning dna
|
US5441884A
(en)
*
|
1993-07-08 |
1995-08-15 |
Ecogen Inc. |
Bacillus thuringiensis transposon TN5401
|
US5843744A
(en)
*
|
1993-07-08 |
1998-12-01 |
Ecogen Inc. |
Bacillus thuringiensis Tn5401 proteins
|
CA2117668C
(en)
*
|
1994-03-09 |
2005-08-09 |
Izumu Saito |
Recombinant adenovirus and process for producing the same
|
EG23907A
(en)
*
|
1994-08-01 |
2007-12-30 |
Delta & Pine Land Co |
Control of plant gene expression
|
US5723765A
(en)
*
|
1994-08-01 |
1998-03-03 |
Delta And Pine Land Co. |
Control of plant gene expression
|
CA2197242A1
(en)
*
|
1994-08-18 |
1996-02-29 |
Joan S. Brugge |
Regulatable elimination of gene expression, gene product function and engineered host cells
|
JP4216350B2
(ja)
*
|
1994-09-19 |
2009-01-28 |
大日本住友製薬株式会社 |
動物細胞感染用の組換えdnaウイルスベクター
|
JP3770333B2
(ja)
*
|
1995-03-15 |
2006-04-26 |
大日本住友製薬株式会社 |
組換えdnaウイルスおよびその製造方法
|
US6130364A
(en)
*
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6091001A
(en)
*
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6974694B2
(en)
*
|
1995-06-07 |
2005-12-13 |
Advec, Inc. |
Adenoviruses for control of gene expression
|
US5629159A
(en)
*
|
1995-06-07 |
1997-05-13 |
California Institute Of Technology |
Immortalization and disimmortalization of cells
|
US6720140B1
(en)
|
1995-06-07 |
2004-04-13 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
US6964861B1
(en)
|
1998-11-13 |
2005-11-15 |
Invitrogen Corporation |
Enhanced in vitro recombinational cloning of using ribosomal proteins
|
NZ312332A
(en)
|
1995-06-07 |
2000-01-28 |
Life Technologies Inc |
Recombinational cloning using engineered recombination sites
|
US20060110798A1
(en)
*
|
1995-06-07 |
2006-05-25 |
Graham Frank L |
Cells expressing recombinase useful for adenovirus vector production and control of gene expression
|
US6143557A
(en)
*
|
1995-06-07 |
2000-11-07 |
Life Technologies, Inc. |
Recombination cloning using engineered recombination sites
|
US5801030A
(en)
*
|
1995-09-01 |
1998-09-01 |
Genvec, Inc. |
Methods and vectors for site-specific recombination
|
US6051409A
(en)
|
1995-09-25 |
2000-04-18 |
Novartis Finance Corporation |
Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
|
US6406847B1
(en)
*
|
1995-10-02 |
2002-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mismatch repair detection
|
US7153652B2
(en)
*
|
1995-10-02 |
2006-12-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mismatch repair detection
|
EP0952767A4
(de)
*
|
1995-11-13 |
2001-10-24 |
Univ Rochester |
Produktion eones somatischen mosaiks in säugetieren unter verwendung eines rekombinatorischen substrates
|
NZ330553A
(en)
*
|
1996-01-05 |
2001-04-27 |
Genetic Therapy Inc |
Recombinase-mediated generation of adenoviral vectors where all adenoviral genes of all regions E1 to E4 and L1 to L5 of the adenoviral genome are eliminated
|
US6087129A
(en)
*
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
US6228646B1
(en)
|
1996-03-07 |
2001-05-08 |
The Regents Of The University Of California |
Helper-free, totally defective adenovirus for gene therapy
|
US6132989A
(en)
*
|
1996-06-03 |
2000-10-17 |
University Of Washington |
Methods and compositions for enhanced stability of non-adenoviral DNA
|
US5928914A
(en)
*
|
1996-06-14 |
1999-07-27 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Methods and compositions for transforming cells
|
US6534314B1
(en)
|
1996-06-14 |
2003-03-18 |
Massachusetts Institute Of Technology |
Methods and compositions for transforming cells
|
US6025192A
(en)
*
|
1996-09-20 |
2000-02-15 |
Cold Spring Harbor Laboratory |
Modified retroviral vectors
|
US6255071B1
(en)
|
1996-09-20 |
2001-07-03 |
Cold Spring Harbor Laboratory |
Mammalian viral vectors and their uses
|
US7332338B2
(en)
|
1996-10-04 |
2008-02-19 |
Lexicon Pharmaceuticals, Inc. |
Vectors for making genomic modifications
|
US20040072243A1
(en)
*
|
1996-10-11 |
2004-04-15 |
Lexicon Genetics Incorporated |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
US6066778A
(en)
*
|
1996-11-06 |
2000-05-23 |
The Regents Of The University Of Michigan |
Transgenic mice expressing APC resistant factor V
|
US5994620A
(en)
*
|
1996-12-10 |
1999-11-30 |
The Jackson Laboratory |
Induced chromosomal deletion
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
US6787319B2
(en)
*
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
US6774279B2
(en)
*
|
1997-05-30 |
2004-08-10 |
Carnegie Institution Of Washington |
Use of FLP recombinase in mice
|
US6284944B1
(en)
|
1997-08-29 |
2001-09-04 |
Cephalon, Inc, |
Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
|
US8563803B2
(en)
*
|
1997-10-16 |
2013-10-22 |
Synageva Biopharma Corp. |
Method of making protein in an egg of a transgenic chicken
|
US20090074718A1
(en)
*
|
1997-10-16 |
2009-03-19 |
Ivarie Robert D |
Avian derived erythropoietin
|
US7511120B2
(en)
*
|
1997-10-16 |
2009-03-31 |
Synageva Biopharma Corp. |
Glycosylated G-CSF obtained from a transgenic chicken
|
US7129390B2
(en)
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
US20040019923A1
(en)
*
|
1997-10-16 |
2004-01-29 |
Ivarie Robert D. |
Exogenous proteins expressed in avians and their eggs
|
AU752946B2
(en)
*
|
1997-10-16 |
2002-10-03 |
Avigenics, Inc. |
Vectors comprising a magnum-specific promoter for avian transgenesis
|
EP1025217B1
(de)
|
1997-10-24 |
2006-10-04 |
Invitrogen Corporation |
Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
|
US7351578B2
(en)
|
1999-12-10 |
2008-04-01 |
Invitrogen Corp. |
Use of multiple recombination sites with unique specificity in recombinational cloning
|
AU757930B2
(en)
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
US6808921B1
(en)
|
1998-03-27 |
2004-10-26 |
Lexicon Genetics Incorporated |
Vectors for gene mutagenesis and gene discovery
|
US6436707B1
(en)
*
|
1998-03-27 |
2002-08-20 |
Lexicon Genetics Incorporated |
Vectors for gene mutagenesis and gene discovery
|
EP1100885A4
(de)
*
|
1998-07-24 |
2001-12-12 |
Baylor College Medicine |
Schnelle subklonierung mittels ortsspezifischer rekombination
|
TWI255853B
(en)
*
|
1998-08-21 |
2006-06-01 |
Kirin Brewery |
Method for modifying chromosomes
|
MXPA01005275A
(es)
|
1998-11-27 |
2003-06-06 |
Darwin Discovery Ltd |
Composiciones y metodos para aumentar la mineralizacion de huesos.
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
AU3387500A
(en)
*
|
1999-03-02 |
2000-09-21 |
Invitrogen Corporation |
Cells resistant to toxic genes and uses thereof
|
CA2363924A1
(en)
|
1999-03-02 |
2000-09-08 |
Invitrogen Corporation |
Compositions and methods for use in recombinational cloning of nucleic acids
|
US6890726B1
(en)
|
1999-04-06 |
2005-05-10 |
Oklahoma Medical Research Foundation |
Method for selecting recombinase variants with altered specificity
|
EP1201759B1
(de)
*
|
1999-07-14 |
2010-03-10 |
Transgenic Inc. |
"gen-fallen-vektor" und verfahren zum "einfangen" von genen mittels dieses vektors
|
CA2373690A1
(en)
|
1999-07-14 |
2001-01-25 |
Clontech Laboratories, Inc. |
Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
|
EP1228237A1
(de)
|
1999-11-01 |
2002-08-07 |
Chiron Corporation |
Expressionsvektoren, transfektionssysteme, und verfahren zur verwendung
|
US7820878B2
(en)
*
|
1999-11-19 |
2010-10-26 |
Kyowa Hakko Kirin Co., Ltd. |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
WO2001035735A1
(en)
*
|
1999-11-19 |
2001-05-25 |
Hematech, Llc |
Production of ungulates, preferably bovines that produce human immunoglobulins
|
US7074983B2
(en)
*
|
1999-11-19 |
2006-07-11 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
|
US7414170B2
(en)
*
|
1999-11-19 |
2008-08-19 |
Kirin Beer Kabushiki Kaisha |
Transgenic bovines capable of human antibody production
|
EP2210948A3
(de)
|
1999-12-10 |
2010-10-06 |
Life Technologies Corporation |
Verwendung von mehrfachen Rekombinationsstellen mit einzigartiger Spezifizität beim Rekombinationsklonen
|
AU1647501A
(en)
|
1999-12-10 |
2001-06-18 |
Cytos Biotechnology Ag |
Replicon based activation of endogenous genes
|
DE10004996C2
(de)
*
|
2000-02-04 |
2002-09-26 |
Infineon Technologies Ag |
Vorrichtung und Verfahren zur Selbstkalibrierung von Faltungs-Analog/Digitalwandlern
|
US7517688B2
(en)
*
|
2000-02-25 |
2009-04-14 |
Stratagene California |
Method for ligating nucleic acids and molecular cloning
|
JP2004503207A
(ja)
*
|
2000-02-25 |
2004-02-05 |
ストラタジーン |
核酸をライゲーションする方法および分子クローニング
|
US6750379B2
(en)
*
|
2000-03-09 |
2004-06-15 |
Dekalb Genetics Corporation |
Homologous recombination-mediated transgene alterations in plants
|
US6580019B1
(en)
|
2000-03-09 |
2003-06-17 |
Dekalb Genetics Corporation |
Non-reciprocal recombination-mediated transgene deletion in transgenic plants
|
US7223395B2
(en)
|
2000-03-13 |
2007-05-29 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2
|
US20040231006A1
(en)
*
|
2000-04-12 |
2004-11-18 |
Silver Daniel P. |
Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
|
US6852530B2
(en)
|
2000-04-12 |
2005-02-08 |
Dana Farber Cancer Institute, Inc. |
Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
|
US7244560B2
(en)
*
|
2000-05-21 |
2007-07-17 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
US7198924B2
(en)
*
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
US7041870B2
(en)
|
2000-11-30 |
2006-05-09 |
Medarex, Inc. |
Transgenic transchromosomal rodents for making human antibodies
|
US7491534B2
(en)
*
|
2000-12-22 |
2009-02-17 |
Kirin Holdings Kabushiki Kaisha |
Methods for altering cell fate to generate T-cells specific for an antigen of interest
|
NZ525607A
(en)
*
|
2000-12-22 |
2005-05-27 |
Aurox Llc |
Methods for cloning mammals using reprogrammed donor chromatin or donor cells
|
US20020142397A1
(en)
*
|
2000-12-22 |
2002-10-03 |
Philippe Collas |
Methods for altering cell fate
|
EP1860199B1
(de)
|
2001-01-12 |
2014-03-05 |
Exelixis, Inc. |
Modulierte Signalisierung von Insulinrezeptoren
|
US7126039B2
(en)
*
|
2001-03-21 |
2006-10-24 |
Geron Corporation |
Animal tissue with carbohydrate antigens compatible for human transplantation
|
US7265262B2
(en)
*
|
2001-03-21 |
2007-09-04 |
Roslin Institute (Edinburgh) |
Telomerizing nuclear donor cells and improving the efficiency on nuclear transfer
|
US20040132042A1
(en)
*
|
2001-04-06 |
2004-07-08 |
Frankard Valerie Marie-Noelle |
Use of double and opposite recombination sites or the single step cloning of two dna segments
|
EP1390394A4
(de)
*
|
2001-04-19 |
2004-05-26 |
Invitrogen Corp |
Zusammensetzungen und verfahren zur rekombinationsklonierung von nukleinsäuremolekülen
|
US20020188965A1
(en)
|
2001-04-20 |
2002-12-12 |
Zou-Yu Zhao |
Methods of transforming plants
|
AU2002309063B8
(en)
|
2001-05-11 |
2008-04-24 |
Kyowa Kirin Co., Ltd. |
Artificial human chromosome containing human antibody lambda light chain gene
|
CA2448505A1
(en)
*
|
2001-05-21 |
2002-11-28 |
Invitrogen Corporation |
Compositions and methods for use in isolation of nucleic acid molecules
|
US20030119104A1
(en)
*
|
2001-05-30 |
2003-06-26 |
Edward Perkins |
Chromosome-based platforms
|
US20030092183A1
(en)
*
|
2001-09-21 |
2003-05-15 |
Fisher Katherine E. |
Rapid creation of gene targeting vectors using homologous recombination in yeast
|
US20040023910A1
(en)
*
|
2001-09-28 |
2004-02-05 |
Zhiming Zhang |
Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
|
EP1652920B1
(de)
|
2001-10-01 |
2010-08-04 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verfahren zur Herstellung von Protein-Bibliotheken und zur Selektion von Proteinen daraus
|
DE10211063A1
(de)
|
2002-03-13 |
2003-10-09 |
Axaron Bioscience Ag |
Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
EP1546395A4
(de)
*
|
2002-07-26 |
2007-05-02 |
Genecopoeia Inc |
Verfahren und nukleinsäurevektoren zur schnellen expression und zum schnellen screening von cdna-klonen
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US20040229230A1
(en)
*
|
2002-08-27 |
2004-11-18 |
Sleckman Barry P. |
Method for gene isolation by Cre-trap cloning
|
US7285699B2
(en)
*
|
2002-10-07 |
2007-10-23 |
Stowers Institute For Medical Research |
Ends-out gene targeting method
|
WO2004042007A2
(en)
*
|
2002-10-30 |
2004-05-21 |
University Of Iowa Research Foundation |
Somatic cell gene targeting vectors and methods of use thereof
|
US20030175968A1
(en)
*
|
2002-10-30 |
2003-09-18 |
Golic Kent G. |
Gene targeting method
|
AU2003290689A1
(en)
|
2002-11-08 |
2004-06-03 |
Kyowa Hakko Kirin Co., Ltd. |
Transgenic ungulates having reduced prion protein activity and uses thereof
|
US7078234B2
(en)
|
2002-12-18 |
2006-07-18 |
Monsanto Technology Llc |
Maize embryo-specific promoter compositions and methods for use thereof
|
AU2004203727C1
(en)
*
|
2003-01-07 |
2008-08-21 |
Symphogen A/S |
Method for manufacturing recombinant polyclonal proteins
|
US20060275766A1
(en)
*
|
2003-01-07 |
2006-12-07 |
Haurum John S |
Method for manufacturing recombinant polyclonal proteins
|
US20040133944A1
(en)
*
|
2003-01-08 |
2004-07-08 |
Delta And Pine Land Company |
Seed oil suppression to enhance yield of commercially important macromolecules
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
US7271313B2
(en)
*
|
2003-04-09 |
2007-09-18 |
The Brigham And Women's Hospital, Inc. |
Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss
|
EP1921152A1
(de)
|
2003-05-05 |
2008-05-14 |
Monsanto Technology, LLC |
Transgene Pflanzen mit Glycin-Betain-spezifischem Promoter
|
EP1662863A4
(de)
*
|
2003-09-18 |
2009-01-28 |
Mayo Foundation |
Transgene nichthumane tieg-tiere
|
JP2007507224A
(ja)
*
|
2003-09-30 |
2007-03-29 |
レキシコン ジェネティックス インコーポレーテッド |
遺伝子の機能を定義するための方法および組成物
|
WO2005033319A2
(en)
|
2003-10-02 |
2005-04-14 |
Monsanto Technology Llc |
Stacking crop improvement traits in transgenic plants
|
EP2287341B1
(de)
|
2003-12-01 |
2013-02-13 |
Life Technologies Corporation |
Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon
|
US20050235370A1
(en)
*
|
2003-12-12 |
2005-10-20 |
National Health Research Institutes |
Spatiotemporally controlled adult somatic mutagenesis system
|
EP1699289B1
(de)
|
2003-12-30 |
2008-11-26 |
Ullevål Universitetssykehus HF |
Nichtmenschliches säugetier mit modifiziertem serca2-gen sowie verfahren, zellen, gene und vektoren hierfür
|
AR047598A1
(es)
|
2004-02-10 |
2006-01-25 |
Monsanto Technology Llc |
Semilla de maiz transgenica con mayor contenido de aminoacidos
|
US7683237B2
(en)
|
2004-02-10 |
2010-03-23 |
Monsanto Technology Llc |
Maize seed with synergistically enhanced lysine content
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
EP1732379B1
(de)
|
2004-04-09 |
2013-11-06 |
Monsanto Technology LLC |
Zusammensetzungen und verfahren zur kontrolle von insektenbefall an pflanzen
|
JP2007533328A
(ja)
|
2004-04-22 |
2007-11-22 |
キリンホールディングス株式会社 |
トランスジェニック動物及びその用途
|
AU2005263334C1
(en)
|
2004-07-20 |
2011-01-20 |
Symphogen A/S |
A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
|
US7582741B2
(en)
|
2004-07-26 |
2009-09-01 |
University Of Massachusetts |
Conditional disruption of dicer1 in cell lines and non-human mammals
|
EP1789437A4
(de)
*
|
2004-07-30 |
2008-11-05 |
Sinai School Medicine |
Npc1l1 und npc1l1-inhibitoren und verfahren zu deren anwendung
|
US20060075522A1
(en)
|
2004-07-31 |
2006-04-06 |
Jaclyn Cleveland |
Genes and uses for plant improvement
|
US20060117398A1
(en)
*
|
2004-10-22 |
2006-06-01 |
Roland Buelow |
Suppression of endogenous immunoglobulin expression
|
US7501275B2
(en)
*
|
2004-10-27 |
2009-03-10 |
The United States Of America As Represented By The Secretary Of Agriculture |
Yeast transformation system
|
EP1817591A2
(de)
*
|
2004-11-23 |
2007-08-15 |
The Government of the United States of America, as represented by the Secretary of Health and Human Services |
Verfahren und zusammensetzungen zur ex-vivo-hochdurchsatzdetektion von protein-protein-wechselwirkungen
|
US20080244765A1
(en)
*
|
2004-12-16 |
2008-10-02 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for pollination disruption
|
CA2941986A1
(en)
|
2004-12-21 |
2006-06-29 |
Monsanto Technology Llc |
Recombinant dna for expression of proteins for imparting enhanced agronomic traits to transgenic plants
|
CA2595171C
(en)
|
2004-12-21 |
2015-03-17 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
AR051895A1
(es)
|
2005-01-07 |
2007-02-14 |
Ard Of Higher Education On Beh |
Metodo para disparar la interferencia de arn
|
EP1850656A4
(de)
|
2005-01-12 |
2010-04-07 |
Monsanto Technology Llc |
Gene und ihre verwendungen für die züchterische bearbeitung von pflanzen
|
US20060174362A1
(en)
|
2005-02-01 |
2006-08-03 |
Origen Therapeutics, Inc. |
Long-term culture of avian primordial germ cells (PGCs)
|
EP2478760A1
(de)
|
2005-05-10 |
2012-07-25 |
Monsanto Technology LLC |
Gene und ihre Verwendung zur Pflanzenverbesserung
|
US8124732B2
(en)
|
2005-06-24 |
2012-02-28 |
Synageva Biopharma Corp. |
Composition comprising isolated human CTLA4-Fc fusion protein produced in a transgenic chicken
|
WO2007005898A2
(en)
*
|
2005-07-05 |
2007-01-11 |
Cornell Research Foundation, Inc. |
Blocking leukocyte emigration and inflammation by interfering with cd99l2
|
US20090215872A1
(en)
*
|
2005-07-07 |
2009-08-27 |
Lee Jeannie T |
Methods for Controlling Stem Cell Differentiation
|
US9121028B2
(en)
*
|
2005-09-09 |
2015-09-01 |
Monsanto Technology Llc |
Selective gene expression in plants
|
ES2614943T3
(es)
|
2005-09-16 |
2017-06-02 |
Monsanto Technology Llc |
Procedimientos para el control genético de infestaciones de insectos en plantas y composiciones de los mismos
|
EP1929020A2
(de)
|
2005-09-16 |
2008-06-11 |
Devgen NV |
Dsrna als mittel zur insektenbekämpfung
|
WO2007041419A1
(en)
|
2005-10-03 |
2007-04-12 |
Monsanto Technology Llc |
Transgenic plant seed with increased lysine
|
CA2625262A1
(en)
*
|
2005-10-13 |
2007-10-04 |
Bc Cancer Agency |
Modular genomes for synthetic biology and metabolic engineering
|
US20070143881A1
(en)
*
|
2005-12-16 |
2007-06-21 |
Pioneer Hi-Bred International, Inc. |
Methods and Compositions for Improving the Efficiency of Site-Specific Polynucleotide Exchange
|
EP2484769A3
(de)
|
2005-12-21 |
2012-09-19 |
Monsanto Technology LLC |
Transgene Pflanzen mit verbesserten agronomischen Merkmalen
|
EP2044109B1
(de)
|
2006-02-10 |
2014-05-21 |
Monsanto Technology, LLC |
Identifizierung und verwendung von zielgenen zur steuerung pflanzenparasitärer nematoden
|
EP2426206B8
(de)
|
2006-02-13 |
2018-10-31 |
Monsanto Technology LLC |
Auswahl und Stabilisierung von dsRNA-Konstrukten
|
US20100070186A1
(en)
*
|
2006-03-15 |
2010-03-18 |
Soper Bryan R |
Methods of screening for and mapping phenotypic and genotypic variations in cells
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
US20070250941A1
(en)
*
|
2006-03-27 |
2007-10-25 |
Genentech, Inc. |
VEGF Receptor Conditional Knockout Animals and Methods of Use
|
US7919322B2
(en)
*
|
2006-03-29 |
2011-04-05 |
Sigma-Aldrich Co. |
Targeted deletions using retroelement-mediated placement of recombination sites
|
EP2010226B1
(de)
|
2006-04-07 |
2014-01-15 |
The Research Foundation of State University of New York |
Transcobalaminrezeptor-Polypeptide, -Nukleinsäuren und -Modulatoren sowie entsprechende Verfahren zur Verwendung für die Modulation von Zellwachstum und die Behandlung von Krebs und Cobalaminmangel
|
CN105002207A
(zh)
|
2006-05-09 |
2015-10-28 |
密苏里大学学监 |
通过端粒截短的植物人工染色体平台
|
WO2008021543A2
(en)
|
2006-08-17 |
2008-02-21 |
Monsanto Technology, Llc |
Transgenic plants with enhanced agronomic traits
|
US8053191B2
(en)
|
2006-08-31 |
2011-11-08 |
Westend Asset Clearinghouse Company, Llc |
Iterative nucleic acid assembly using activation of vector-encoded traits
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
US8975068B2
(en)
*
|
2007-01-25 |
2015-03-10 |
The General Hospital Corporation |
Isolated stem cell comprising a Xic flanking region transgene
|
WO2008091311A1
(en)
|
2007-01-26 |
2008-07-31 |
Synageva Biopharma Corp |
Transgene expression in avians
|
EP2113029A4
(de)
*
|
2007-02-09 |
2010-06-02 |
Univ Utah Res Found |
In vivo genomweite mutagenese
|
WO2008103474A1
(en)
|
2007-02-20 |
2008-08-28 |
Anaptysbio, Inc. |
Methods of generating libraries and uses thereof
|
US20100115640A1
(en)
*
|
2007-03-09 |
2010-05-06 |
The Curators Of The University Of Missouri |
Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
|
DE102007041655A1
(de)
|
2007-09-03 |
2009-03-05 |
Medicyte Gmbh |
Vermehrung von primären Zellen und deren Verwendung
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
MX344415B
(es)
|
2007-09-14 |
2016-12-15 |
Adimab Inc |
Bancos de anticuerpos sinteticos, designados racionalmente y usos para los mismos.
|
EP2612868B1
(de)
|
2007-11-01 |
2018-08-15 |
Astellas Pharma Inc. |
Immunsuppressive Polypeptide und Nucleinsäuren
|
FR2927089B1
(fr)
|
2008-02-05 |
2011-03-25 |
Inst Nat De La Rech Agronomique Inra |
Procede d'integration ciblee de multicopies d'un gene d'interet dans une souche de yarrowia
|
US20090233809A1
(en)
*
|
2008-03-04 |
2009-09-17 |
Affymetrix, Inc. |
Resequencing methods for identification of sequence variants
|
US8093043B2
(en)
*
|
2008-06-04 |
2012-01-10 |
New York University |
β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
|
EP2310517B1
(de)
*
|
2008-07-11 |
2016-03-16 |
Institut National De La Recherche Agronomique (INRA) |
Neue hefestammmutanten mit fähigkeit zur anhäufung grosser lipidmengen
|
WO2010017248A2
(en)
|
2008-08-04 |
2010-02-11 |
University Of Miami |
Sting (stimulator of interferon genes), a regulator of innate immune responses
|
WO2010042490A1
(en)
*
|
2008-10-06 |
2010-04-15 |
Boston Medical Center Corporation |
A single lentiviral vector system for induced pluripotent (ips) stem cells derivation
|
US20110258735A1
(en)
|
2008-12-22 |
2011-10-20 |
Marie Coffin |
Genes and uses for plant enhancement
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
EP2206723A1
(de)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modulare DNA-bindende Domänen
|
AU2010230985B2
(en)
|
2009-04-03 |
2015-09-24 |
United Kingdom Research And Innovation |
Mutants of activation-induced cytidine deaminase (AID) and methods of use
|
US8455716B2
(en)
|
2009-04-20 |
2013-06-04 |
Monsanto Technology Llc |
Multiple virus resistance in plants
|
EP2449112A1
(de)
|
2009-07-01 |
2012-05-09 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für schwere kombinierte immundefizienz (scid)
|
US8558055B2
(en)
|
2009-07-24 |
2013-10-15 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
|
WO2011014721A2
(en)
|
2009-07-30 |
2011-02-03 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for pharmacokinetics
|
EP2461672A2
(de)
*
|
2009-08-05 |
2012-06-13 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für arzneimittelstoffwechsel
|
EP2467013A2
(de)
|
2009-08-20 |
2012-06-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetisch modifizierte rattenmodelle für schmerz
|
US20120315670A1
(en)
|
2009-11-02 |
2012-12-13 |
Gen9, Inc. |
Compositions and Methods for the Regulation of Multiple Genes of Interest in a Cell
|
TR201815882T4
(tr)
|
2009-12-10 |
2018-11-21 |
Univ Iowa State Res Found Inc |
Tal efektörü aracılı dna modifikasyonu.
|
CN103025344B
(zh)
|
2010-05-17 |
2016-06-29 |
桑格摩生物科学股份有限公司 |
新型dna-结合蛋白及其用途
|
EP2597945B1
(de)
|
2010-07-26 |
2020-07-22 |
Trianni, Inc. |
Transgene tiere und verfahren zu ihrer verwendung
|
DE102010041958A1
(de)
|
2010-10-04 |
2012-04-05 |
Medicyte Gmbh |
Geeignete Hepatozyten für in-vitro Genotoxitätstests
|
US10457935B2
(en)
|
2010-11-12 |
2019-10-29 |
Gen9, Inc. |
Protein arrays and methods of using and making the same
|
EP3360963B1
(de)
|
2010-11-12 |
2019-11-06 |
Gen9, Inc. |
Verfahren und vorrichtungen für nukleinsäuresynthese
|
DK2640743T3
(en)
|
2010-11-16 |
2017-01-23 |
Excelimmune Inc |
PROCEDURES FOR THE PREPARATION OF RECOMBINANT PROTEINS
|
WO2012129198A1
(en)
|
2011-03-23 |
2012-09-27 |
Transposagen Biopharmaceuticals, Inc. |
Genetically modified rat models for obesity and diabetes
|
EP2734632A1
(de)
|
2011-07-21 |
2014-05-28 |
The Regents of the University of California |
Transkriptionsfaktoren zur herstellung von zelluloseabbauenden enzymen
|
AU2012300401B2
(en)
|
2011-08-26 |
2018-02-08 |
Gen9, Inc. |
Compositions and methods for high fidelity assembly of nucleic acids
|
US9150853B2
(en)
|
2012-03-21 |
2015-10-06 |
Gen9, Inc. |
Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
|
CN104364259A
(zh)
|
2012-03-26 |
2015-02-18 |
普罗努塔利亚公司 |
营养性片段、蛋白质和方法
|
WO2013163263A2
(en)
|
2012-04-24 |
2013-10-31 |
Gen9, Inc. |
Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
|
EP2861737B1
(de)
|
2012-06-19 |
2019-04-17 |
Regents Of The University Of Minnesota |
Gen-targeting in pflanzen durch dns-viren
|
CN104685116A
(zh)
|
2012-06-25 |
2015-06-03 |
Gen9股份有限公司 |
用于核酸组装和高通量测序的方法
|
EP2690177B1
(de)
|
2012-07-24 |
2014-12-03 |
Technische Universität Dresden |
Protein mit Rekombinase-Aktivität zur ortspezifischen DNA-Rekombination
|
BR112015009967B1
(pt)
|
2012-11-01 |
2022-07-12 |
Medicago Inc. |
Método para a produção de um polipeptídeo terapêutico
|
TR201808715T4
(tr)
|
2012-12-21 |
2018-07-23 |
Cellectis |
Düşük soğuk indüklü tatlandırması olan patatesler.
|
AU2014207618A1
(en)
|
2013-01-16 |
2015-08-06 |
Emory University |
Cas9-nucleic acid complexes and uses related thereto
|
US10113162B2
(en)
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
EP2810952A1
(de)
|
2013-06-03 |
2014-12-10 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Neuartige Schädlingsbekämpfungsverfahren
|
EP2927685A1
(de)
|
2014-04-02 |
2015-10-07 |
Medicyte GmbH |
Geeignete Hepatozyten für In-vitro-Hepatitistests
|
WO2015193858A1
(en)
|
2014-06-20 |
2015-12-23 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
WO2015200281A1
(en)
|
2014-06-24 |
2015-12-30 |
The Regents Of The University Of California |
Methods for production of xylosyl-xylitol oligomers
|
FR3028527A1
(fr)
|
2014-11-13 |
2016-05-20 |
Pivert |
Identification de facteurs de transcription de yarrowia lipolytica
|
CN107529762A
(zh)
|
2015-04-13 |
2018-01-02 |
弗劳恩霍夫应用研究促进协会 |
新型黄曲霉毒素和真菌感染控制方法
|
CN106191041B
(zh)
*
|
2015-04-30 |
2020-12-29 |
杭州菁因康生物科技有限公司 |
基因打靶方法
|
US20180291353A1
(en)
|
2015-05-28 |
2018-10-11 |
The Regents Of The University Of California |
Monofunctional aldehyde and alcohol dehydrogenases for production of fuels and commodity chemicals
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
WO2017128039A1
(zh)
*
|
2016-01-26 |
2017-08-03 |
浙江大学 |
基因组合及其用途
|
UY37108A
(es)
|
2016-02-02 |
2017-08-31 |
Cellectis |
Modificación de la composición de aceites de soja mediante el knockout dirigido de los genes fad3a/b/c
|
US11421212B2
(en)
|
2016-08-05 |
2022-08-23 |
Cargill, Incorporated |
Engineered yeast strains with signal sequence-modified glucoamylase polypeptides and enhanced ethanol production
|
EP3504334B1
(de)
|
2016-08-26 |
2023-12-06 |
Board of Trustees of Michigan State University |
Transkriptionsfaktoren zur verbesserung der resistenz gegenüber umweltstress bei pflanzen
|
UY37482A
(es)
|
2016-11-16 |
2018-05-31 |
Cellectis |
Métodos para alterar el contenido de aminoácidos en plantas mediante mutaciones de desplazamiento de marco
|
WO2018198049A1
(en)
|
2017-04-25 |
2018-11-01 |
Cellectis |
Alfalfa with reduced lignin composition
|
US11046969B2
(en)
|
2017-05-24 |
2021-06-29 |
Epiplanta Biotech Ltd. |
Transgenic plant and the method for producing the same
|
WO2018228961A1
(en)
|
2017-06-12 |
2018-12-20 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Genetic tools and procedure for the phenotypic identification of the genotype of transgenic diploid organisms
|
JP7402503B2
(ja)
|
2017-06-14 |
2023-12-21 |
テクニスチェ ユニベルシタト ドレスデン |
デザイナーdna組換え酵素を利用したゲノムを遺伝的に改変するための方法及び手段
|
US20190002874A1
(en)
|
2017-06-30 |
2019-01-03 |
Inscripta, Inc. |
Cell libraries created using rationally designed nucleic acids
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
CN111372650A
(zh)
|
2017-09-30 |
2020-07-03 |
因思科瑞普特公司 |
流通式电穿孔仪器
|
EP3737766A4
(de)
|
2018-01-09 |
2021-11-24 |
Cibus US LLC |
Bruchsichere gene und mutationen
|
US10435662B1
(en)
|
2018-03-29 |
2019-10-08 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
WO2019209926A1
(en)
|
2018-04-24 |
2019-10-31 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
CA3108767A1
(en)
|
2018-06-30 |
2020-01-02 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
CN112955540A
(zh)
|
2018-08-30 |
2021-06-11 |
因思科瑞普特公司 |
在自动化模块和仪器中对经核酸酶经编辑的序列的改进的检测
|
US10920189B2
(en)
|
2019-06-21 |
2021-02-16 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
CN114502725A
(zh)
|
2019-07-01 |
2022-05-13 |
特里安尼公司 |
转基因哺乳动物及使用方法
|
CN114554841A
(zh)
|
2019-07-01 |
2022-05-27 |
特里安尼公司 |
转基因哺乳动物及其使用方法
|
BR112021026832A2
(pt)
|
2019-07-02 |
2022-05-10 |
Hutchinson Fred Cancer Res |
Vetores ad35 recombinantes e aprimoramentos da terapia gênica relacionada
|
US11939588B2
(en)
|
2019-10-17 |
2024-03-26 |
Board Of Trustees Of Michigan State University |
Elevated resistance to insects and plant pathogens without compromising seed production
|
EP3825408A1
(de)
|
2019-11-19 |
2021-05-26 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Verfahren zur insektenschädlingsbekämpfung für mehrere arten
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
JP2024503719A
(ja)
|
2021-01-19 |
2024-01-26 |
ザ ジェイ. デビッド グラッドストーン インスティテューツ、 ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ. デビッド グラッドストーン |
ヒトt細胞の機能を強化するための遺伝子活性化標的
|
CA3216988A1
(en)
|
2021-05-05 |
2022-11-10 |
Werner Mueller |
Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof
|
CA3235395A1
(en)
|
2021-11-10 |
2023-05-19 |
Peter Burrows |
Transgenic mammals and methods of use thereof
|
WO2023150393A2
(en)
|
2022-02-07 |
2023-08-10 |
Ensoma, Inc. |
Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids
|
WO2023156906A1
(en)
|
2022-02-15 |
2023-08-24 |
Futuragene Israel Ltd |
A bacillus thuringiensis pesticidal protein (bt pp) combination useful for plant protection
|